On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
With risk-appropriate regulation, UK electronic health records can facilitate large-scale studies. AgeX, the largest randomised treatment trial ever conducted, can assess realistically small effects of one extra mammographic screening invitation. Three million potentially compliant women have been randomised between invitation and control, and electronic follow-up is monitoring the effects on breast cancer incidence, treatment, and mortality.
